BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 30, 2007
View Archived Issues
Utility of I-123 MIBG in diagnosis of neuroblastomas
Read More
AZ-001 meets two-hour pain-relief endpoint in migraine
Read More
Topline results for CRx-139 in RA
Read More
Recent patents cover new therapeutic agents for cancer
Read More
Recent University of Dundee patent describes novel wound-healing agents
Read More
New therapeutic agents for gastrointestinal disorders reported in recent patents
Read More
New experimental data on sildenafil-doxazosin combination
Read More
INO-1001 evaluated in phase II study
Read More
BAY-68-4986 reduces heart rate in chronic angina patients
Read More
BMS-695735: a novel, improved IGF-1R inhibitor reported by BMS
Read More
ABT-888, a new PARP inhibitor, shows antitumor activity in several cancer models
Read More
Azixa studied in phase II for melanoma patients with brain metastases
Read More
AL-108 cleared for clinical study in schizophrenia-related cognitive impairment
Read More
Phase II trial evaluates belinostat with bortezomib in refractory multiple myeloma
Read More
HZT-501 begins phase II program for mild to moderate pain relief
Read More
Neugranin begins phase I/IIa study for neutropenia
Read More
United Therapeutics and Mochida sign Japanese agreement for Remodulin
Read More
CytoGenix and USAMRIID collaborate on biodefense vaccines
Read More
Phase IIb kidney transplant trial of ISA-247 clears interim review
Read More
Zyvox increases risk of death in patients with Gram-negative infections
Read More
BrainCells and Lundbeck form CNS research collaboration
Read More
Collaborative compound PS-386113 begins phase I for inflammatory disease
Read More
Phase III trial evaluates Zingo in adults
Read More
FDA accepts for review PMA for Repel-CV
Read More
Merck and Lundbeck discontinue gaboxadol development
Read More
BLA submission for Cervarix
Read More
GSK files Globorix meningococcal vaccine
Read More
E.U. approval for Xeloda for advanced stomach cancer
Read More